Upload anastasiabove
View 16
Download 0
Embed Size (px) 344 x 292 429 x 357 514 x 422 599 x 487
Citation preview
PARKINSON’S PROGRESSION MARKERS INITIATIVEPPMI Data BLITZ. Longitudinal . alpha-synuclein measurements in CSF. Brit Mollenhauer and Douglas Galasko, Biologics Working Group. 0 12
Does Transmission Of Pathological Alpha-Synuclein (A -Syn
Preclinical development of a vaccine against oligomeric alpha-synuclein … · 2017. 11. 15. · gated alpha-synuclein [6–9]. Alpha-synuclein (a-syn) is an abundant protein in the
SIL23 a-Synuclein Tracer
-Synuclein in Parkinson’s Disease - Cold Spring Harborperspectivesinmedicine.cshlp.org/content/2/2/a009399.full.pdf · a-Synuclein in Parkinson’s Disease Leonidas Stefanis Laboratory
Alpha-Synuclein: The Gateway to Parkinsonism- Innsbruck
M-CSF and GM-CSF Receptor Signaling Differentially ... · Priority Report M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization
Direct visualization of alpha-synuclein oligomers reveals previously
Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration … · RESEARCH ARTICLE SUMMARY NEURODEGENERATION Poly(ADP-ribose) drives pathologic a-synuclein neurodegeneration
Mounting Evidence that Endocytosis Regulates -Synuclein Degradation
Herpes simplex reactivation following neurosurgery: case ......Until LP CSF Glucose* CSF Protein* CSF WBCs/mm 3 CSF Lymph (%) CSF PMNs (%) PCR Status Aldea et al., 2003 Rt frontocingular
The Slow Axonal Transport of Alpha-Synuclein— Mechanistic ...€¦ · The Slow Axonal Transport of Alpha-Synuclein— Mechanistic Commonalities Amongst Diverse Cytosolic Cargoes
Validation of α-Synuclein as a CSF Biomarker for Sporadic … · 2020. 1. 21. · Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease Franc Llorens1,2
Alpha-Synuclein and the Immune Response in Parkinson s Disease · plasma from PD and multiple system atrophy (MSA) patients relative to age-matched controls (Lee et al., 2006), while
CEREBROSPINAL FLUID CSF - kanpuruniversity.orgkanpuruniversity.org/pdf/Cerebrospinal-fluid(CSF)-Analysis_070520.pdf · What is CSF? CSF is a clear, color less fluid that surrounds
Kordower · synuclein Kordower et al., Neurobiology of Disease, in press. Synuclein Ubiquitin Synuclein Ubiquitin Host nigra Grafted neurons Kordower et al. Nat Med 2009;34:254. 1965-1968
Interaction between Neuromelanin and Alpha-Synuclein in
Anti-amyloid compounds inhibit alpha-synuclein aggregation
Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades ... · Characterization of the different α-synuclein protein preparations Wild-type and mutant α-synuclein proteins were
Early Detection of ParkinsonEarly Detection of Parkinson s’s … · Total alpha-synuclein levels in CSF biological fluids, e.g., ‐synuclein (total, oligomeric, modified variants);
Potential Pathways of Abnormal Tau and -Synuclein ...cshperspectives.cshlp.org/content/8/11/a023630.full.pdfa-Synuclein Dissemination in Sporadic Alzheimer’s and Parkinson’s Diseases
Native ±-synuclein induces clustering of synaptic-vesicle
Neuropathology in Mice Expressing Human α-Synuclein
Characterization of R-Synuclein Interactions with Selected
-Synuclein: Multiple System Atrophy Prionsperspectivesinmedicine.cshlp.org/content/early/2017/02/...2017/02/17 · Multiple system atrophy (MSA) is a rapidly progressive neurodegenerative
DISORDERED PROTEIN -SYNUCLEIN: A REPLICA EXCHANGE
Synuclein Toxicity by Targeting Neuroactive-Ligand
BASIS OF -SYNUCLEIN DEGRADATION: Emerging Support for Multiple Pathways BASIS OF -SYNUCLEIN DEGRADATION: Emerging Support for Multiple Pathways Jessica
Neurotoxicity of pre-incubated alpha-synuclein with …scientiairanica.sharif.edu/article_4419_f84c94416bd3cb19... · 2018-06-30 · Neurotoxicity of pre-incubated alpha-synuclein
Structural and functional characterization of two alpha-synuclein
![Preclinical development of a vaccine against oligomeric alpha-synuclein … · 2017. 11. 15. · gated alpha-synuclein [6–9]. Alpha-synuclein (a-syn) is an abundant protein in the](https://img.pdfslide.us/doc/110x75/5fc07f533588d914ed7a20f9/preclinical-development-of-a-vaccine-against-oligomeric-alpha-synuclein-2017-11.jpg)
